Savara Inc (SVRA)
4.81
+0.01
(+0.21%)
USD |
NASDAQ |
Apr 19, 16:00
4.81
0.00 (0.00%)
After-Hours: 18:12
Savara Enterprise Value: 527.14M for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 527.14M |
| April 17, 2024 | 549.24M |
| April 16, 2024 | 576.87M |
| April 15, 2024 | 560.30M |
| April 12, 2024 | 564.44M |
| April 11, 2024 | 601.74M |
| April 10, 2024 | 518.85M |
| April 09, 2024 | 540.95M |
| April 08, 2024 | 510.56M |
| April 05, 2024 | 524.38M |
| April 04, 2024 | 500.89M |
| April 03, 2024 | 525.76M |
| April 02, 2024 | 509.18M |
| April 01, 2024 | 532.67M |
| March 28, 2024 | 552.01M |
| March 27, 2024 | 534.05M |
| March 26, 2024 | 542.34M |
| March 25, 2024 | 529.90M |
| March 22, 2024 | 527.14M |
| March 21, 2024 | 539.57M |
| March 20, 2024 | 539.57M |
| March 19, 2024 | 535.43M |
| March 18, 2024 | 514.71M |
| March 15, 2024 | 514.71M |
| March 14, 2024 | 507.80M |
| Date | Value |
|---|---|
| March 13, 2024 | 539.57M |
| March 12, 2024 | 543.72M |
| March 11, 2024 | 542.34M |
| March 08, 2024 | 596.21M |
| March 07, 2024 | 636.28M |
| March 06, 2024 | 612.77M |
| March 05, 2024 | 614.15M |
| March 04, 2024 | 625.20M |
| March 01, 2024 | 576.85M |
| February 29, 2024 | 561.65M |
| February 28, 2024 | 567.18M |
| February 27, 2024 | 596.19M |
| February 26, 2024 | 585.14M |
| February 23, 2024 | 571.32M |
| February 22, 2024 | 542.31M |
| February 21, 2024 | 527.12M |
| February 20, 2024 | 529.88M |
| February 16, 2024 | 550.60M |
| February 15, 2024 | 550.60M |
| February 14, 2024 | 554.75M |
| February 13, 2024 | 524.35M |
| February 12, 2024 | 554.75M |
| February 09, 2024 | 538.17M |
| February 08, 2024 | 522.97M |
| February 07, 2024 | 517.45M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-51.98M
Minimum
Nov 14 2019
636.28M
Maximum
Mar 07 2024
111.98M
Average
36.42M
Median
Jan 31 2020
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.485M |
| Palatin Technologies Inc | 21.01M |
| iBio Inc | 16.03M |
| Theriva Biologics Inc | -12.54M |
| Ampio Pharmaceuticals Inc | -3.814M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.10M |
| Total Expenses (Quarterly) | 17.63M |
| EPS Diluted (Quarterly) | -0.09 |
| Earnings Yield | -6.86% |
| Normalized Earnings Yield | -17.56 |